Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy
Authors:
Open Access
- 9 June 2021
- journal article
- research article
- Published by Springer Nature in Esophagus
- Vol. 18 (4) , 817-824
Abstract
Background: Talaporfin sodium photodynamic therapy (tPDT) is an effective salvage treatment for local failure after chemoradiotherapy for esophageal cancer. Repeated tPDT could also be indicated for local recurrence or residue after the first salvage tPDT. However, the safety and efficacy of repeated tPDT have not been elucidated. Methods: We reviewed 52 patients with esophageal cancer who were treated with the first tPDT at Kyoto University Hospital between October 2015 and April 2020. Results: Among 52 patients, repeated tPDT after the first tPDT was indicated for 13 patients (25%), of which six had residual tumor, four had local recurrence after complete response (CR) after the first tPDT at the primary site, and six had metachronous lesion. The total session of repeated tPDT was 25; 16 were for primary sites and nine were for metachronous sites. Among them, six patients (46.2%) achieved local (L)-CR and nine lesions (56.3%) achieved lesion L-CR. By session, 10 sessions (40%) achieved L-CR. There were no severe adverse events except for one patient; this patient showed grade 3 esophageal stenosis and perforation after the third tPDT on the same lesion that was previously treated with porfimer sodium photodynamic therapy four times. Conclusion: Repeated tPDT could be an effective and safe treatment for local failure even after salvage tPDT for esophageal cancer.Keywords
Funding Information
- Meiji Seika Pharma
This publication has 17 references indexed in Scilit:
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell CarcinomaGastroenterology, 2015
- Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancerDiseases of the Esophagus, 2013
- Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinomaEndoscopy, 2008
- Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancerThe American Journal of Surgery, 2004
- Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2–3Nany M0 squamous cell carcinoma of the esophagusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancerGastrointestinal Endoscopy, 2003
- Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapyThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992